Zhaoke Ophthalmology Enters into Exclusive License, Supply and Distribution Agreement with Eyedetec Medical to Commercialize Eye Lipid Mobilizer™ for the Treatment of Dry Eye Disease
Zhaoke Ophthalmology’s Partner Vyluma Announces FDA Acceptance of New Drug Application for NVK002, its Novel Investigational Treatment for Pediatric Myopia
Zhaoke Ophthalmology’s Partner Visus Therapeutics Announces Positive Topline Clinical Data from Phase 3 Pivotal BRIO-I Trial of BRIMOCHOL PF™ for the Treatment of Presbyopia
